BARCELONA, Spain, May 20 /PRNewswire/ -- InspireMD, Ltd. announced today the completion of enrolment for the MAGICAL trial (MGuard(TM) in Acute Myocardial). The trial was designed to confirm the clinical feasibility, safety and performance of MGuard when used during Primary PCI in STEMI patients.

The MAGICAL trial is a multicenter, prospective, single arm, 60 patients study (Principal investigator: Dr. Dariusz Dudek, Jagiellonian University, Krakow, Poland). Primary end-points are incidence of complete ST segment resolution measured 60 minutes post procedure and incidence of TIMI 3 flow after PCI. Main secondary endpoints are myocardial blush grade and MACE (major adverse cardiac events) at discharge, 30 days and 6 months.

HUNTINGTON BEACH, California and AMSTERDAM, May 21 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that leading researchers from Agendia, the University of California San Francisco and the Netherlands Cancer Institute will present data from multiple studies at the American Society of Clinical Oncology Annual Meeting, May 29 - June 2, 2009, in Orlando, Florida.

The study results further underpin the broad predictive and prognostic power of Agendia's breast cancer recurrence test MammaPrint(R) and highlight promising data on Agendia's new colon cancer recurrence test, ColoPrint(TM). Visitors can meet the Agendia team in booth #2014 and study results will be discussed at the following sessions:

INDIANAPOLIS, May 21 /PRNewswire/ --

- Both Phase III pivotal trials begin enrollment in May 2009; Reinforces Lilly's commitment to Alzheimer's disease and biotech product research

Eli Lilly and Company (NYSE: LLY) today announced it will begin enrolling patients this month in two separate but identical Phase III clinical trials of solanezumab(i), previously referred to as LY2062430, an anti-amyloid beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease. The trials, called EXPEDITION and EXPEDITION 2, will each include a treatment period that lasts 18 months and are expected to enroll a total of 2,000 patients age 55 and over from 16 countries.

LONDON, May 21 /PRNewswire/ --

- Former Minister of State for Trade Industry Addresses the CPiO Customer Conference in Warwickshire

Speaking at the CPiO Customer Conference 2009 http://www.cpio.co.uk/conference09/ former Minister of State for Trade Investment and Head of the CBI, Digby, Lord Jones of Birmingham Kt. implored SMEs to focus upon maintaining their level of business fitness to ensure that they are ready to take advantage of the upswing in the economy when it occurs.

PRAGUE, May 21 /PRNewswire/ --

- Ointment (Tacrolimus Monohydrate) in a New Twice-Weekly Regimen can Help Prevent Eczema Flares

LONDON, May 21 /PRNewswire/ -- The Society for the Protection of Unborn Children (SPUC) has commented on last year's abortion statistics for England and Wales, which have just been published.

Paul Tully, SPUC general secretary, said: The scandal of government backed abortions is reflected in these figures, which show the highest ever number of NHS-funded abortions. State provision of abortion is now a major aspect of government policy - a policy which hurts women and kills unborn children.

For the first time, in 2008 the majority of abortions were performed in private clinics at the NHS' expense.

CHICAGO and LONDON, May 21 /PRNewswire/ --

- Launched Today by Imagepick Inc., VIVOZOOM Radically Changes the Commercial Image Market by Offering Warranted Stock Photography at Microstock Prices

Extensive market research in North America and Europe has revealed an unmet demand for guaranteed high-quality imagery at Microstock prices. VIVOZOOM's unique offering will allow image buyers the opportunity to license high-quality images at affordable prices without compromising their requirements for legal guarantees.

LONDON, May 21 /PRNewswire/ --

- Each year, the momentum behind HD Masters grows, and this year will be no different

The 4th annual HD Masters 2009 conference is brought to you by TVB Europe in partnership with SMPTE and the BKSTS. It is the European event for excellence in high definition production, infrastructure and delivery to the home.

HAIFA, Israel, May 21 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (the Company), Israel's largest oil refiner, announced that on May 17, 2009 a request for the classification of a legal claim as a class action claim, as defined in Action Law - 2006 (hereinafter: the Request), was filed with the Haifa District Court against the Company and Carmel Olefins Ltd. (hereinafter: the Responders).

The Request was filed with respect to non-monetary damages caused, according to the Requestor, as a result of two smoke emissions events which occurred on September 15, 2003 and October 5, 2003 (hereinafter: the Events), with regards to which three prior requests for classification of the claims as class action have already been submitted, two of which are still pending.

LONDON, May 21 /PRNewswire/ --

- New Survey From IT Outsourcing Consultancy and Multi Sourcing Advisors, PA Consulting Group, Confirms That the Risks Associated With Multi Sourcing Strategies for Managed IT Sourcing Contracts is Poorly Understood and Significant in Value

Summary of PA Consulting Group survey results http://tinyurl.com/PAG-ITS